ADO and neoplasm: Then, we pay special attention to the strategies of combining various nanomaterials (including phospholipids and polymers-based nanomaterials, mesoporous nanomaterials, biomimetic nanomaterials and metal-based nanomaterials) with ADO pathway inhibitors to enhance tumor immunotherapy.